English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

SFDA Initiates Reform of the Approval Process for Innovative Drugs

Feb. 27, 2013

On February 28, 2013, the SFDA announced it was considering changes to its drug approval process. According to the standing proposal, the “first-come, first-served” basis for examination of all drug candidates will be changed to give priority to innovative drug candidates. In particular, drug-candidates indicated for unmet needs will be given a special “fast-track” treatment.